In a paper published in Clinical Cancer Research, Ken He Young, MD, PhD, and Zijun Yidan Xu-Monette, PhD, explore the lymphoma clinical and biological features using next generation sequencing and biological technology in diffuse large B-cell lymphoma (DLBCL).

Sarah Bean, MD, Vice Chair of Faculty, was featured in a new Washington Post series that charts a single day in women’s working lives.

Before Donald Nelson Love (1907-1985) arrived at Duke Hospital on the morning of June 2, 1930, to begin his first day of work, he had never seen the place before. The hospital and medical school were still under construction, a month away from opening.

Duke Pathology is grateful for our residents, fellows, program directors and coordinators, and celebrates them this Duke GME Week, Feb. 21-25, 2022.

Dr. Mikhail Nikiforov’s group published a study that has uncovered a novel regulatory signal transduction pathway by Ephrin Receptors in melanoma.

Andrea T. Deyrup, M.D., Ph.D., has authored an article along with Joseph L. Graves, Jr., Ph.D., titled “Racial Biology and Medical Misconceptions” that was released in the February 5th  2022 issue of The New England Journal of Medicine.

Dr. Michael Datto, MD, PHD, FCAP, and Dr. Diana M. Cardona, MD, FCAP, are featured for their leadership of the Clinical Laboratories at Duke University Health System during the pandemic in the February 2022 College of American Pathologists’ Executive Briefing.

Please join us in welcoming Francis J. Sun, DVM, DACLAM, MBA, to the Department of Pathology as an Assistant Professor. 

Prostate cancer cells rely on an amino acid called glutamine to fuel their rapid growth and invasive behavior, as reported by Dr.

Pathology Chair Jiaoti Huang, M.D., Ph.D., is senior author of a groundbreaking study that identifies a molecular signal that can be developed into a test to identify patients in need prostate cancer treatment early in their diagnosis.